DORIBAX PACKAGE INSERT PDF

Based on reported adverse drug reactions, it is not anticipated that Doribax will affect the ability to .. PACKAGE LEAFLET: INFORMATION FOR THE USER. Based on reported adverse drug reactions, it is not anticipated that Doribax will affect the ability to drive and Package leaflet: Information for the user. Doribax . Doripenem is an antibacterial drug. Bacterial resistance mechanisms that affect doripenem include drug inactivation . Package Insert data.

Author: Mezinris Akinos
Country: South Sudan
Language: English (Spanish)
Genre: Politics
Published (Last): 10 February 2012
Pages: 295
PDF File Size: 5.16 Mb
ePub File Size: 9.71 Mb
ISBN: 636-1-54539-548-3
Downloads: 94969
Price: Free* [*Free Regsitration Required]
Uploader: Kirn

In pooled human liver microsomes, no in vitro metabolism of doripenem could be detected, indicating that doripenem is not a substrate for hepatic Doribas enzymes. The magnitude of this value, coupled with the significant decrease in the elimination of doripenem with concomitant probenecid administration, suggests that doripenem undergoes both glomerular filtration and active tubular secretion.

Anaerobic microorganisms Bacteroides caccae Bacteroides fragilis Bacteroides thetaiotaomicron Bacteroides uniformis Bacteroides vulgatus Peptostreptococcus micros. Although cross-resistance may occur, some isolates resistant to other carbapenems may be susceptible to doripenem. Facultative Gram-negative microorganisms Acinetobacter baumannii Escherichia coli Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Facultative Gram-positive microorganisms Streptococcus constellatus Streptococcus intermedius Anaerobic microorganisms Bacteroides caccae Bacteroides fragilis Bacteroides thetaiotaomicron Bacteroides uniformis Bacteroides vulgatus Peptostreptococcus micros At least 90 percent of the following microorganisms exhibit an in vitro minimal inhibitory concentration MIC less than or equal to the susceptible breakpoint for doripenem of organisms of the same type shown in Table 6.

Microbiology Doripenem belongs to the carbapenem class of antimicrobials.

Patients with seizure disorders controlled with valproic acid or sodium valproate will therefore be at an increased risk for breakthrough seizures. Pharmacodynamics———————————— Similar to other beta-lactam antimicrobial agents, the time that unbound plasma concentration of doripenem exceeds the MIC of the infecting organism has been shown to best correlate with efficacy in animal models of infection. The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment.

  ASPIRADO DE MEDULA OSEA Y BIOPSIA DE HUESO PDF

The final infusion solution concentration is approximately 4. The recommended dosage and administration by infection is described in Table 1: The following formula may be used to estimate CrCl.

Doripenem for Injection, MG, 10 POWDER (VIAL)

Variations in color within this range do not affect the potency of the product. When culture and susceptibility information are available, they should be considered in selecting and modifying antibacterial therapy. Patients with Renal Impairment Table 2: Doripenem is a carbapenem with in vitro antibacterial activity against aerobic and anaerobic Gram-positive and Paclage bacteria.

Reference s National Institutes of Health, U. Please review the latest applicable package insert for additional information and possible updates. Excretion Doripenem is primarily eliminated unchanged by the kidneys. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Aseptic technique must be followed in preparation of the infusion solution. Evaluate if diarrhea occurs.

Doripenem for Injection

The mean plasma terminal elimination half-life of doripenem in healthy non-elderly adults is approximately 1 hour and mean SD plasma clearance is Doripenem is stable to hydrolysis by most beta-lactamases, including penicillinases and cephalosporinases produced by Gram-positive and Gram-negative bacteria, with the exception of carbapenem hydrolyzing beta-lactamases.

Storage of Constituted Solutions Upon constitution with sterile water doeibax injection or 0. Mechanism s of Resistance Bacterial resistance mechanisms that affect doripenem include drug inactivation by carbapenem-hydrolyzing enzymes, mutant or acquired PBPs, decreased outer membrane permeability and active efflux.

Facultative Gram-positive microorganisms Streptococcus constellatus Streptococcus intermedius. Facultative Gram-positive microorganisms Staphylococcus aureus methicillin-susceptible isolates only Streptococcus agalactiae Streptococcus pyogenes.

Doripenem inactivates multiple essential penicillin-binding proteins PBPs resulting in inhibition of cell wall synthesis with subsequent cell death.

Metabolism Metabolism of doripenem to a microbiologically inactive ring-opened metabolite doripenem-M1 occurs primarily via dehydropeptidase-I.

DORIBAX® (doripenem) powder – GlobalRPH

A local search option of this data can be found here. Reference Package Insert data. The serum creatinine used in the formula should represent a steady state of renal function.

  GAROFALO CRIMINOLOGY PDF

Facultative Gram-positive microorganisms Staphylococcus aureus methicillin-susceptible isolates only Streptococcus agalactiae Streptococcus pyogenes Facultative Gram-negative microorganisms Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Klebsiella oxytoca Morganella morganii Serratia marcescens Pharmacodynamics———————————— Similar to other beta-lactam antimicrobial pcakage, the time that unbound plasma concentration of doripenem exceeds the MIC of the infecting organism has been shown to best correlate with efficacy in animal models of infection.

Facultative Gram-negative inaert Acinetobacter baumannii Escherichia coli Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa. Mechanism of Action Doripenem is an antibacterial drug.

Doripenem has been shown to be active against most isolates of the following microorganisms, both in vitro and in clinical infections. At least 90 percent of the following microorganisms exhibit an in vitro minimal inhibitory concentration MIC less than or equal to the susceptible breakpoint for doripenem of organisms of the same type shown in Table 6.

Facultative Gram-negative microorganisms Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Klebsiella oxytoca Morganella morganii Serratia marcescens. Doripenem exerts its bactericidal activity by inhibiting bacterial cell wall biosynthesis. The safety and efficacy of doripenem in treating clinical infections due to these microorganisms has not been established in adequate and well-controlled clinical trials.

Mean SD renal clearance is Interaction with Other Antimicrobials In vitro synergy tests with doripenem show doripenem has little potential to antagonize or be antagonized by other antibiotics e. Disclaimer Odribax authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use whenever solution and container permit.

Posted in: Medical